Error: Could not add to watchlist. X
+ Watchlist

Halozyme Therapeutics Inc

HALO:US
NASDAQ GS
12.41
USD
0.19
1.51%
As of 8:10 PM EDT 5/26/2017
Open
12.52
Day Range
12.36 - 12.64
Volume
671,809
Previous Close
12.60
52Wk Range
7.70 - 15.20
1 Yr Return
24.10%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
12.52
Day Range
12.36 - 12.64
Volume
671,809
Previous Close
12.60
52Wk Range
7.70 - 15.20
1 Yr Return
24.10%
YTD Return
25.61%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.91
Market Cap (b USD)
1.735
Shares Outstanding (m)
139.822
Price/Sales (TTM)
11.90
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.21%
% Price Change
-0.28%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
Profile
Halozyme Therapeutics, Inc. is a biopharmaceutical company developing products for the diabetes, cancer, dermatology, and drug delivery markets. The Company's platform technology is based on recombinant human hyaluronidase plus additional enzymes. Halozyme applies its technology to its proprietary programs and to partnerships with pharmaceutical companies.
Address
11388 Sorrento Valley Road
San Diego, CA 92121
United States
Phone
1-858-794-8889
Show More